Roche will invest $50 billion in U.S. manufacturing, including a new plant in Indiana. The Trump administration is considering tariffs on drugmakers.

Swiss pharmaceutical leader Roche revealed on Tuesday its intention to allocate USD50 billion in the United States for pharmaceuticals and diagnostic

With threats of tariffs hanging over the pharmaceutical industry, Switzerland’s Roche announced on Tuesday that it will invest $50 billion in the United States over the next five years, expanding its existing facilities and building new manufacturing plants and research centers.